AQR Capital Management
IRON icon

AQR Capital Management’s Disc Medicine IRON Stock Holding History

AQR Capital Management’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$905K Buy
14,155
+148
+1% +$10.3K ﹤0.01% 2824
2025
Q4 		$1.11M Buy
14,007
+29
+0.2% +$2.45K ﹤0.01% 2487
2025
Q3 		$924K Buy
13,978
+329
+2% +$19.6K ﹤0.01% 2481
2025
Q2 		$723K Buy
+13,649
New +$641K ﹤0.01% 2401
2022
Q1 		– Sell
-422
Closed -$37K – 2250
2021
Q4 		$37K Hold
422
– – ﹤0.01% 2184
2021
Q3 		$51K Buy
+422
New +$57.7K ﹤0.01% 2225

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

AQR Capital Management's IRON Position: Q1 2026 in Review

AQR Capital Management increased its Disc Medicine (IRON) stake by 1.1% in Q1 2026, buying an estimated $10.3K and bringing the position to 14,155 shares worth $905K. The position accounts for ﹤0.01% of the portfolio, ranked #2824.

AQR Capital Management first reported a position in IRON in Q3 2021 and has held it in 6 quarters since. The position peaked at $1.11M in Q4 2025. 203 funds tracked by Wall St. Rank hold IRON as of Q1 2026.

  • AQR Capital Management held 14,155 shares of Disc Medicine worth $905K as of Q1 2026.
  • AQR Capital Management bought 148 Disc Medicine shares in Q1 2026, an estimated $10.3K.
  • Disc Medicine made up ﹤0.01% of AQR Capital Management's portfolio in Q1 2026, its #2824 holding.
  • AQR Capital Management first reported a position in Disc Medicine in Q3 2021 and has held it in 6 quarters since.
  • AQR Capital Management's Disc Medicine position peaked at $1.11M in Q4 2025.
  • 203 funds tracked by Wall St. Rank held Disc Medicine as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.